{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:31:09Z","timestamp":1792315869331,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.urology.2011.04.070","type":"journal-article","created":{"date-parts":[[2011,8,17]],"date-time":"2011-08-17T04:44:37Z","timestamp":1313556277000},"page":"848-854","source":"Crossref","is-referenced-by-count":25,"title":["Diminished Efficacy of Bacille Calmette-Gu\u00e9rin Among Elderly Patients with Nonmuscle Invasive Bladder Cancer"],"prefix":"10.1016","volume":"78","author":[{"given":"David","family":"Margel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan S.","family":"Alkhateeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Finelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Fleshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2011.04.070_bib1","series-title":"Campbell\u2013Walsh Urology","first-page":"2407","article-title":"Urothelial tumors of the bladder","author":"Messing","year":"2008"},{"issue":"3","key":"10.1016\/j.urology.2011.04.070_bib2","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-5347(17)35678-1","article-title":"T-cell subsets required for intravesical BCG immunotherapy for bladder cancer","volume":"150","author":"Ratliff","year":"1993","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urology.2011.04.070_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.immuni.2006.05.003","article-title":"Aging and innate immunity","volume":"24","author":"Solana","year":"2006","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.urology.2011.04.070_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-4933-5-11","article-title":"Immunity, ageing and cancer","volume":"24","author":"Derhovanessian","year":"2008","journal-title":"Immun Ageing"},{"issue":"3","key":"10.1016\/j.urology.2011.04.070_bib5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","article-title":"Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer","volume":"170","author":"B\u00f6hle","year":"2003","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urology.2011.04.070_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1474-9728.2004.00106.x","article-title":"Immunity and aging: the enemy within?","volume":"3","author":"DeVeale","year":"2004","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.urology.2011.04.070_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.urology.2007.03.024","article-title":"Age and outcome of superficial bladder cancer treated with Bacille Calmette\u2013Gu\u00e9rin therapy","volume":"70","author":"Herr","year":"2007","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.urology.2011.04.070_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.juro.2010.03.022","article-title":"Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors","volume":"184","author":"Alkhateeb","year":"2010","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urology.2011.04.070_bib9","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0022-5347(05)00973-0","article-title":"The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy","volume":"175","author":"Joudi","year":"2006","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urology.2011.04.070_bib10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jjco\/hyq241","article-title":"Could Patient Age Influence Tumor Recurrence Rate in non-muscle-invasive Bladder Cancer Patients Treated with BCG Immunotherapy?","volume":"41","author":"Yuge","year":"2011","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"10.1016\/j.urology.2011.04.070_bib11","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette\u2013Gu\u00e9rin: multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urology.2011.04.070_bib12","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.070_bib13","series-title":"Campbell's Urology","first-page":"2789","article-title":"Management of superficial bladder cancer","author":"Malkowicz","year":"2002"},{"issue":"2","key":"10.1016\/j.urology.2011.04.070_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.urolonc.2007.04.005","article-title":"Effect of advanced age on the development of complications from intravesical bacillus Calmette\u2013Gu\u00e9rin therapy","volume":"26","author":"Heiner","year":"2008","journal-title":"Urol Oncol"},{"issue":"12","key":"10.1016\/j.urology.2011.04.070_bib15","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1464-410X.2009.09072.x","article-title":"Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy","volume":"105","author":"Shariat","year":"2010","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.urology.2011.04.070_bib16","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.juro.2009.06.026","article-title":"Fibrin clot inhibitor medication and efficacy of bacillus Calmette-Guerin for bladder urothelial cancer","volume":"182","author":"Boorjian","year":"2009","journal-title":"J Urol"},{"issue":"355","key":"10.1016\/j.urology.2011.04.070_bib17","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1056\/NEJMc062714","article-title":"Use of statins and outcome of BCG treatment for bladder cancer","volume":"21","author":"Hoffmann","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429511006364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429511006364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T03:29:43Z","timestamp":1560482983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429511006364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0090429511006364"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2011.04.070","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}